VOMIVIB MD 4 (DPCO)ONDANSETRON 4mg. IP

Vomivib MD 4 tablets contain Ondansetron 4 mg and are used to prevent nausea and vomiting from chemotherapy, radiotherapy and surgery. Main uses: prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin at 50 mg/m2 or above; prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy; prevention of nausea and vomiting associated with radiotherapy, including total body irradiation, a single high-dose fraction to the abdomen, or daily fractions to the abdomen; prevention of postoperative nausea and/or vomiting.

Common side effects of Vomivib MD 4 Tablet include headache; malaise or fatigue; constipation; diarrhoea; hypoxia (mainly after operations). Get medical help at once if you notice hypersensitivity reactions, including anaphylaxis and bronchospasm; heart and circulation problems: prolongation of the QT interval with torsade de pointes, and myocardial ischaemia; serotonin syndrome, mainly with concomitant serotonergic drugs.

Each Vomivib MD 4 tablet contains Ondansetron 4 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Vomivib MD 4 Tablet only as your doctor advises.

The MRP of Vomivib MD 4 Tablet is ₹55.23 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹42.08 and the PTS is ₹37.87.

Each Vomivib MD 4 tablet contains Ondansetron 4 mg. It comes in a pack of 10x10 (Alu Alu).

Ondansetron blocks 5-HT3 serotonin receptors on vagal nerve terminals in the gut and in the chemoreceptor trigger zone of the brain. Cytotoxic chemotherapy can release serotonin from the small intestine, and this serotonin starts the vomiting reflex. By blocking the receptors, the tablet helps keep that signal from being passed on; it does not act on dopamine receptors.

Must not be used by patients known to have hypersensitivity (e.g. anaphylaxis) to ondansetron or any component of the formulation. Must not be used together with apomorphine, because of the risk of a profound drop in blood pressure and loss of consciousness. Should be avoided in patients with congenital long QT syndrome. Check with a doctor first if there are electrolyte abnormalities, cardiac failure or arrhythmias, or use of other QT-prolonging medicines; ECG monitoring is advised in these situations. Check with a doctor first if the patient is taking serotonergic medicines.

Vomivib MD 4 Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.